CD30+ lymphoma simulating orf

González, Lucía Carnero; Murua, María Asunción Arregui; Ortega, Raúl; Río, Irene García; Urra, Izaskun Trébol; Michelena, Itziar Arrue; Oyón, Nieves Saracíbar; Arechavala, Ricardo Soloeta

doi:10.1111/j.1365-4632.2008.04064.x

Cited by 4 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The benign CD30+ lymphomatoid reactions in the skin are termed "CD30+ T cell pseudolymphomas" (CD30+ PSL) and are observed in settings of viral, bacterial, and parasitic infections, drug reactions, and inflammatory conditions [12][13][14]. The most commonly encountered clinical settings for CD30+ PSL in a review of 28 cases of by Werner et al included viral infections by parapox (8 cases), herpes (8 cases), and molluscipox (3 cases) viruses and drug reaction [3,5].…”

Section: Case Discussionmentioning

confidence: 99%

Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma

Shalabi¹,

Ringe²,

Lee³

et al. 2019

Dermatology Online Journal

View full text Add to dashboard Cite

Section: Case Discussionmentioning

confidence: 99%

Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma

Shalabi¹,

Ringe²,

Lee³

et al. 2019

Dermatology Online Journal

View full text Add to dashboard Cite

“…CD30+ PSL has been associated with arthropod‐bite reaction, scabies infection (esp. as persistent nodules in scabies), and virus infections (especially molluscum contagiosum, orf or ecthyma contagiosum, milker's nodule, and herpesvirus infection) . Lesions caused traumatically by coals or lymphomatoid drug reactions can also contain CD30+ cells.…”

Section: Classification Of Pseudolymphomamentioning

confidence: 99%

Cutaneous pseudolymphoma—A review on the spectrum and a proposal for a new classification

2019

View full text Add to dashboard Cite

Cutaneous pseudolymphomas (PSLs) belong to a group of lymphocytic infiltrates that histopathologically and/or clinically simulate lymphomas. Different causative agents (e.g., Borrelia sp., injected substances, tattoo, arthropod bite) have been described, but in many cases no cause can be identified, hence the term idiopathic PSL. Clinicopathological correlation is important to make the diagnosis. Four main groups of cutaneous PSL can be distinguished based on histopathologic and/or clinical presentation: (a) nodular PSL; (b) pseudo-mycosis fungoides (pseudo-MF) and simulators of other CTCLs; (c) other PSL (representing distinct clinical entities); and (d) intravascular PSL. This article gives an overview of the histopathologic and clinical characteristics of cutaneous PSLs and proposes a new classification.

show abstract

Inflammatory and infectious skin diseases presenting as cutaneous pseudolymphoma

Mitteldorf

2021

Diagnostic Histopathology

View full text Add to dashboard Cite

Cutaneous pseudolymphomas are a heterogeneous group of reactive lymphocytic infiltrates, which simulates cutaneous lymphomas clinically and histologically. Although in many cases the pathogenesis is not understood, a broad spectrum of different agents inducing pseudolymphomas has been reported. Cutaneous pseudolympomas are distinguished in four main groups: (a) nodular pseudolymphomas, (b) pseudo-mycosis fungoides (pseudo-MF) and simulators of other CTCLs, (c) other pseudolymphomas and (d) an intravascular pseudolymphoma. This article focuses on pseudolymphoma entities related to infections or inflammatory skin diseases. The integration of the clinical presentation and patients' history is mandatory for the correct diagnosis.

show abstract

CD30+ lymphoma simulating orf

Cited by 4 publications

References 11 publications

Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma

Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma

Cutaneous pseudolymphoma—A review on the spectrum and a proposal for a new classification

Inflammatory and infectious skin diseases presenting as cutaneous pseudolymphoma

Contact Info

Product

Resources

About